Troy A. Ignelzi - 14 Jun 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
-$423,268
Form type
4
Filing time
16 Jun 2021, 19:01:27 UTC
Previous filing
12 May 2021
Next filing
23 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $20,682 +2,248 +17% $9.20* 15,248 16 Jun 2021 Direct
transaction KRTX Common Stock Sale $291,004 -2,248 -15% $129.45 13,000 16 Jun 2021 Direct
transaction KRTX Common Stock Options Exercise $8,280 +900 +6.9% $9.20* 13,900 14 Jun 2021 Direct
transaction KRTX Common Stock Sale $119,268 -900 -6.5% $132.52 13,000 14 Jun 2021 Direct
transaction KRTX Common Stock Options Exercise $3,238 +352 +2.7% $9.20* 13,352 16 Jun 2021 Direct
transaction KRTX Common Stock Sale $45,197 -352 -2.6% $128.40 13,000 16 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2,248 -18% $0.000000 10,031 16 Jun 2021 Common Stock 2,248 $9.20 Direct F1
transaction KRTX Option (right to buy) Options Exercise $0 -900 -36% $0.000000 1,605 14 Jun 2021 Common Stock 900 $9.20 Direct F1
transaction KRTX Option (right to buy) Options Exercise $0 -352 -22% $0.000000 1,253 16 Jun 2021 Common Stock 352 $9.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on April 1, 2019.